ALX Oncology Holdings (ALXO)
(Delayed Data from NSDQ)
$15.36 USD
-1.26 (-7.58%)
Updated May 3, 2024 04:00 PM ET
After-Market: $15.35 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.87 | 0.00% |
Earnings Summary
For their last quarter, ALX Oncology Holdings (ALXO) reported earnings of -$0.93 per share, missing the Zacks Consensus Estimate of -$0.84 per share. This reflects a negative earnings surprise of 10.71%. Look out for ALXO's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.87 per share, reflecting a year-over-year decrease of 50%.
Earnings History
Price & Consensus
Zacks News for ALXO
ALX Oncology (ALXO) Posts Upbeat Results From Lymphoma Study
ALXO: What are Zacks experts saying now?
Zacks Private Portfolio Services